{
    "SPADE_UN_18892": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_18892",
            "Peptide Name": "L125 (AI predicted AMPs, temporin, Leu-rich, XXA, UCLL1c)",
            "Source": "AI predicted, machine learning prediction, like natural derivative",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "FLPLIGGLLSKLL",
            "Sequence Length": 13,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 1383.76,
            "PI": 8.75,
            "Hydrophobicity": 1.77,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Yin K, Xu W, Ren S, Xu Q, Zhang S, Zhang R, Jiang M, Zhang Y, Xu D, Li R.2024",
                    "Reference": "Interdiscip Sci. 2024 Feb 28. doi: 10.1007/s12539-024-00612-3.PubMed",
                    "Title": "Machine Learning Accelerates De Novo Design of Antimicrobial Peptides."
                }
            ],
            "Frequent Amino Acids": "LGF",
            "Absent Amino Acids": "ACDEHMNOQRTUVWY",
            "Basic Residues": 1,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 9,
            "Polar Residues": 2,
            "Positive Residues": 1,
            "Negative Residues": 0,
            "Net Charge": 1,
            "Comments": "Sequence analysis: APD analysis reveals that this sequence is most similar (84.62%) topredicted L32L: 46%.Activity: active against L. monocytogenes (MIC 31.25 ug/ml), MDR strains B. subtilis (MIC 3.19 ug/ml), S. aureus 9 (MIC 62.5 ug/ml), S. sciuri P254 (MIC 62.5 ug/ml), Streptococcus Sc181 (MIC 15.63 ug/ml), L. monocytogenes (MIC 7.81 ug/ml), Enterococcus E1478F (MIC 3.91 ug/ml), S. aureus RN4220 (MIC 62.5 ug/ml).",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_02657",
                    "Similarity": 1.0,
                    "Sequence": "SKLLVRMWK"
                },
                {
                    "SPADE_ID": "SPADE_UN_08069",
                    "Similarity": 1.0,
                    "Sequence": "SKLLKSTNFQYVFRLGLSISRKNIKHAYRRNKIKRLIRETFRLLQHRLDFVVIAKKNIVYLNNKKIVNILE"
                },
                {
                    "SPADE_ID": "SPADE_UN_18495",
                    "Similarity": 1.0,
                    "Sequence": "SKLLKSTNFQRLGLSISRKNIKHAYRRNKIKRLIRELDFVVIVNIL"
                }
            ]
        }
    }
}